Functional domains of tat required for efficient human immunodeficiency virus type 1 reverse-transcription

Journal of Virology

Volumn 73, Issue 3, 1999, Pages 2499-2508

  Ulich, Catherine ^a   Dunne, Amanda ^b,c   Parry, Emma ^b   Hooker, C William ^b   Gaynor, Richard B ^a   Harrich, David ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b ROYAL CHILDREN'S HOSPITAL   (Australia)

^c AIDS Pathogenesis Research Unit   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; TRANSACTIVATOR PROTEIN; TRANSFER RNA; VIRUS RNA;

ARTICLE; CONTROLLED STUDY; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HELA CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS GENOME; VIRUS REPLICATION; VIRUS TRANSCRIPTION;

EID: 0033053593     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.3.2499-2508.1999     Document Type: Article

References (80)

1. Aiken, C., and D. Trono. 1995. nef stimulates human immunodeficiency virus type 1 proviral DNA synthesis. J. Virol. 69:5048-5056.
2. Albini, A., R. Benelli, M. Presta, M. Rusnati, M. Ziehe, A. Rubartelli, G. Paglialunga, F. Bussolino, and D. Noonan. 1996. HIV-lat pnitcin is a heparin-binding angiogenic growth factor. Oncogene 12:284-297.
3. Albini, A., R. Soldi, D. Giunciuglio, E. Giraudo, R. Benelli, L. Primo, D. Noonan, M. Salio, G. Camussi, W. Rockl, and F. Bussolino. 1996. The angiogenesis induced by HIV-1 tat protein is mediated by the Flk-1/KDR receptor on vascular endothelial cells. Nat. Med. 2:3371-1375.
4. Baltimore, D. 1970. RNA-dependent DNA polymerization in virions of RNA tumor viruses. Nature 226:1209-1211.
5. Barat, C., S. F. Le Grice, and J. L. Darlix. 1991. Interaction of HIV-1 reverse transcriptase with a synthetic form of its replication primer, tRNA(Lys,3). Nucleic Acids Res. 19:751-757.
6. Barat, C., O. Schatz, S. U Grice, and J. L. Darlix. 1993. Analysis of the interactions of HIV-1 replication primer tRNA(Lys3) with nucleocapsid protein and reverse transcriptase. J. Mol Biol. 231:185-190.
7. Borgatti, P., G. Zauli, L. C. Cantley, and S. Capitani. 1998. Extracellular HIV-1 Tat protein induces a rapid and selective activation of protein kinase C (PKC)-alpha, and -epsilon and -zeta isoforms in PC12 cells. Biochem. Biophys. Res. Commun. 242:332-337.
8. Borgatti, P., G. Zauli, M. L. Colamussi, D. Gibellini, M. Previati. L. L. Cantley, and S. Capitani. 1997. Extracellular HIV-1 Tat protein activates phosphatidylinositol 3-and Akt/PKB kinases in CD4+ T lymphoblastoid Jurkat cells. Eur. J. Immunol. 27:2805-2811.
9. Bukrinskaya, A. G., A. Ghorpade, N. K. Heinzinger, T. E. Smithgall, R. E. Lewis, and M. Stevenson. 1996. Phosphorylation-dependent human immunodeficiency virus type 1 infection and nuclear targeting of viral DNA. Proc. Natl. Acad. Sci. USA 93:367-371.
10. Bukrinsky, M. I., N. Sharova, M. P. Dempsey, T. L. Stanwick, A. G. Bukrinskaya, S. Haggerty, and M. Stevenson. 1992. Active nuclear import of human immunodeficiency virus type 1 preintegration complexes. Proc. Natl. Acad. Sci. USA 89:6580-6584.
11. Bukrinsky, M. I., N. Sharova, T. L. McDonald, T. Pushkarskaya, W. G. Tarpley, and M. Stevenson. 1993. Association of integrase. matrix, and reverse transcriptase antigens of human immunodeficiency virus type 1 with viral nucleic acids following acute infection. Proc. Natl. Acad. Sci. USA 90:6125-6129.
12. Cartier, C., M. Deckert, C. Grangeasse, R. Trauger, F. Jensen, A. Bernard, A. Cozzone, C. Desgranges, and V. Boyer. 1997. Association of ERK2 mitogen-activated protein kinase with human immunodeficiency virus particles. J. Virol. 71:4832-4837.
13. Conant, K., M. Ma, A. Nath, and E. O. Major. 1996. Extracellular human immunodeficiency virus type 1 Tat protein is associated with an increase in both NF-kappa B binding and protein kinase C activity in primary human astrocyles. J. Virol. 70:1384-1389.
14. Cujec, T. P., H. Cho, E. Maldonado, J. Meyer, D. Reinberg, and B. M. Peterlin. 1997. The human immunodeficiency virus transactivator Tat interacts with the RNA polymerase II holoenzyme. Mol. Cell. Biol. 17:1817-1823.
15. Cujec, T. P., H. Okamoto, K. Fujinaga, J. Meyer, H. Chamberlin, D. O. Morgan, and B. M. Peterlin. 1997. The HIV transactivator TAT binds to the CDK-activating kinase and activates the phosphorylation of the carhoxyterminal domain of RNA polymerase II. Genes Dev. 11:2645-2657.
16. Dayton, A. I., J. G. Sodroski, C. A. Rosen, W. C. Goh, and W. A. Haseltine. 1986. The trans-activator gene of the human T cell lymphotropic virus type III is required for replication. Cell 44:941-947.
17. Dhawan, S., R. K. Puri, A. Kumar, H. Duplan, J. M. Masson, and B. B. Aggarwal. 1997. Human immunodeficiency virus-1-tal protein induces the cell surface expression of endothelial leukocyte adhesion molecule-1, vascular cell adhesion molecule-1. and intercellular adhesion molecule-1 in human endothelial cells. Blood 90:1535-1544.
18. Dingwall, C., I. Ernberg, M. J. Gait, S. M. Green, S. Heaphy, J. Kam, A. D. Lowe, M. Singh, M. A. Skinner, and R. Valerio. 1989. Human immunodeficiency virus 1 Tat protein hinds trans-activation-responsive region (TAR) RNA in vitro. Proc. Natl. Acad. Sci. USA 86:6925-6929.
19. Ensoli, B., G. Barillari, S. Z. Salahuddin, R. C. Gallo, and S. F. Wong. 1990. Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients. Nature 345:84-86.
20. Ensoli, B., R. Gendelman, P. Markham, V. Fiorelli, S. Colombini, M. Raffeld, A. Cafaro, H. K. Chang, J. N. Brady, and R. C. Gallo. 1994. Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma. Nature 371:674-680.
21. Feng, S., and E. C. Holland. 1988. HIV-1 Tat trans-activation requires the loop sequence within TAR. Nature 334:165-167.
22. Fisher, A. G., M. B. Feinberg, S. F. Josephs, M. E. Harper, L. M. Marselle, G. Reyes, M. A. Gonda, A. Aldovini, C. Debnuk, R. C. Gallo, and F. WongStaal. 1186. The trans-activator gene of HTLV-III is essential for virus replication. Nature 320:367-371.
23. Franke, E. K., H. E. H. Yuan, and J. Luban. 1994. Specific incorporation of cyclophilin A into HIV-1 virions. Nature 372:359-362.
24. Gallay, P., S. Swingler, C. Aiken, and H. Trono. 1995. HIV-1 infection of nondividing cells: C-terminal tyrosine phosphorylation of the viral matrix protein is a key regulator. Cell 80:379-388.
25. Gallay, P., S. Swingler, J. Song, F. Bushman, and D. Trono. 1995. HIV nuclear import is governed by the phosphotyrosine-mediated binding of matrix to the core domain of integrase. Cell 83:569-576.
26. Ganju, R. K., N. Munshi, B. C. Nair, Z. Y. Liu, P. Gill, and J. E. Groopman. 1998. Human immunodeficiency virus Tat modulates the Flk-1/KDR receptor, mitogen-activated protein kinases, and components of focal adhesion in Kaposi's sarcoma cells. J. Virol. 72:6131-6137.
27. Garcia, J. A., D. Harrich, L. Pearson, R. Mitsuyasu, and R. B. Gaynor. 1988. Functional domains required for tat-induced transcriptional activation of the HIV-1 long terminal repeat. EMBO J. 7:3143-3147.
28. García-Martínez, L. F., G. Mavankal, J. Neveu, W. Lane, D. Sigman, D. Ivanov, and R. B. Gaynor. 1997. Purification of a Tat associated kinase reveals a TFIIH complex that modulates HIV-1 transcription. EMBO J. 16:2836-2850.
29. Gaynor, R. 1992. Cellular transcription factors involved in the regulation of HIV-1 gene expression. AIDS 6:347-363.
30. Graham, F. L., J. Smiley, W. C. Russell, and R. Nairn. 1977. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36:59-72.
31. Guo, J., L. E. Henderson, J. Bess, B. Kane, and J. G. Levin. 1997. Human immunodeficiency virus type 1 nucleocapsid protein promotes efficient strand transfer and specific viral DNA synthesis by inhibiting TAR-dependent self-priming from minus-strand strong-stop DNA. J. Virol. 71:5178-5188.
32. Hahn, B. H., G. M. Shaw, S. K. Arya, M. Popovic, R. C. Gallo, and S. F. Wong. 1984. Molecular cloning and characterization of the HTLV-III virus associated with AIDS. Nature 312:166-169.
33. Harrich, D., and R. Gaynor. Unpublished observations.
34. Harrich, D., C. Hsu, E. Race, and R. B. Gaynor. 1994. Differential growth kinetics are exhibited by human immunodeficiency virus type 1 TAR mutants. J. Virol. 68:5899-5910.
35. Harrich, D., C. Ulich, L. F. Garcia-Martinez, and R. B. Gaynor. 1997. Tat is required for efficient HIV-1 reverse transcription. EMBO J. 16:1224-1235.
36. Harrich, D., C. Ulich, and R. B. Gaynor. 1996. A critical role for the TAR element in promoting efficient human immunodeficiency virus type 1 reverse transcription. J. Virol. 70:4017-4027.
37. Harrich, D., C. Ulich, and R. B. Gaynor. 1996. A novel role for the human immunodeficiency type 1 TAR element: a critical regulator of viral reverse transcription. J. Virol. 70:4017-4027.
38. Heinzinger, N. K., M. I. Bukinsky, S. A. Haggerty, A. M. Ragland, V. Kewalramani, M. A. Lee, H. E. Gendelman, L. Ratner, M. Stevenson, and M. Emerman. 1994. The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells. Proc. Natl. Acad. Sci. USA 91:7311-7315.
39. Hirt, B. 1967. Selective extraction of polyoma DNA from infected mouse cell cultures. J. Mol. Biol. 26:365-369.
40. Huang, L., A. Joshi, R. Willey, J. Orenstein, and K. T. Jeang. 1994. Human immunodeficiency viruses regulated by alternative trans-activators: genetic evidence for a novel non-transcriptional function of Tat in virion infectivity. EMBO J. 13:2886-2896.
41. 3 genomic placement and initiation of reverse transcription in human immunodeficiency virus type 1. J. Virol. 72:3907-3915.
42. Huber, H. E., J. M. McCoy, J. S. Seehra, and C. C. Richardson. 1989. Human immunodeficiency virus 1 reverse transcriptase. Template binding, processivity, strand displacement synthesis, and template switching. J. Biol Chem. 264:4669-4678.
43. Isel, C., C. Ehresmann, G. Keith, B. Ehresmann, and R. Marquet. 1995. Initiation of reverse transcription of HIV-1: secondary structure of the HIV-1 RNA/tRNA(Lys3) (template primer) complex. J. Mol. Biol. 247:236-250.
44. Isel, C., J.-M. Lanchy, S. F. J. L. Grice, B. Ehresmann, and R. Marquet. 1996. Specific initiation and switch to elongation of human immunodeficiency virus type 1 reverse transcription require the post-transcriptional modifications of primer tRNALys3. EMBO J. 15:917-924.
45. Isel, C., R. Marquet, G. Keith, C. Ehresmann, and B. Ehresmann. 1993 Modified nucleotides of tRNA (3Lys) modulate primer/template loop-loop interaction in the initiation complex of HIV-1 reverse transcriptase. J. Biol. Chcm. 268:25269-25272.
46. Jacque, J. M., A. Mann, H. Enslen, N. Sharova, B. Brichacek, R. J. Davis, and M. Stevenson. 1998. Modulation of HIV-1 infectivity by MAPK, a virion-assodated kinase. EMBO J. 17:2607-2618.
47. Jones, K. A., and B. M. Peterlin. 1994. Control of RNA initiation and elongation at the HIV-1 promoter. Annu. Rev. Biochem. 63:717-743.
48. Kiernan, R. E., A. Ono, G. Englund, and E. O. Freed. 1998. Role of matrix in an early postentry step in the human immunodeficiency virus type 1 life cycle. J. Virol. 72:4116-4126.
49. Kumar, A., S. K. Manna, S. Dhawan, and B. B. Aggarwal. 1998. HIV-Tat protein activates c-Jun N-terminal kinase and activator protein-1. J. Immunol. 161:776-781.
50. Lafrenie, R. M., L. M. Wahl, J. S. Epstein, K. M. Yamada, and S. Dhawan. 1997. Activation of monocytes by HIV-Tat treatment is mediated by cytokine expression. J Immunol. 159:4077-4083.
51. Lanchy, J.-M., C. Ehresmann, S. F. J. Le Grice, B. Ehresmann, and R. Marquel. 1996. Binding and kinetic properties of HIV-1 reverse transcriptase markedly differ during initiation and elongation of reverse transcription. EMBO J. 15:7178-7187.
52. Lapadat-Tapolsky, M., H. De Rocoquigny, D. Van Gent, B. Roques, R. Plasterk, and J. L. Darlix. 1993. Interactions between HIV-1 nucleocapsid protein and viral DNA may have important functions in the viral life cycle. Nucleic Acids Res. 21:831-839. (Erratum, 21:2024.)
53. Lapadat-Tapolsky, M., C. Gabus, M. Rail, and J. L. Darlix. 1997. Possible roles of HIV-1 nucleocapsid protein in the specificity of proviral DNA synthesis and in its variability. J. Mol. Biol. 268:250-260.
54. Li, C. J., D. J. Friendman, C. Wang, V. Meteleve, and A. B. Pardee. 1995 Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein. Science 268:429-431.
55. 3 in vitro: studies of viral RNA molecules mutated in regions that flank the primer binding site. J. Virol. 70:4996-5004.
56. Mancebo, H. S. Y., G. Lee, J. Flygare, J. Tomassini, P. Luu, Y. Zhu, J. Peng, C. Blau, D. Hazuda, D. Price, and O. Flores. 1997. P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro. Genes Dev. 11:2633-2644.
57. Masuda, T., V. Planelles, P. Krogstad, and I. S. Y. Chen. 1995. Genetic analysis of human immunodeficiency virus type 1 integrase and the U3 att site: unusual phenotype of mutants in the zinc finger-like domain. J. Virol. 69:6687-6696.
58. Mely, Y., H. de Rocquigny, M. Sorinas-Jimeno, G. Keith, B. P. Roques, R. Marquet, and D. Gerard. 1995. Binding of the HIV-1 nucleocapsid protein to the primer tRNA(3Lys), in vitro, is essentially not specific. J. Biol. Chem. 270:1650-1656.
59. Menegon, A, C. Leoni, F. Benfenati, and F. Valtorta. 1997. Tat protein from HIV-1 activates MAP kinase in granular neurons and glial cells from rat cerebellum. Biochem. Biophys. Res. Commun. 238:800-805.
60. Milani, D., M. Mazzoni, P. Borgatti, G. Zauli, L. Cantley, and S. Capitani. 1996, Extracellular human immunodeficiency virus type-1 Tat protein activates phosphatidylinositol 3-kinuse in PC12 neuronal cells. J. Biol. Chem. 271:22961-22964.
61. Mitota, S., S. Sozzani, W. Luini, L. Primo, A. Borsatti, H. Weich, and F. Bussolino. 1997. Tat-human immunodeficiency virus-1 induces human monocyte chemotaxis by activation of vascular endothelial growth factor receptor-1. Blood 90:1365-1372.
62. New, D. R., S. B. Maggirwar, L. G. Epstein, S. Dewhurst, and H. A. Gelbard. 1998. HIV-1 Tat induces neuronal death via tumor necrosis factor-alpha and activation of non-N-methyl-D-aspartate receptors by a NFkappaB-independent mechanism. J. Biol. Chem. 273:17852-17858.
63. Opalenik, S. R., J. T. Shin, J. N. Wehby, V. K. Mahesh, and J. A. Thompson. 1995. The HIV-1 TAT protein induces the expression and extracellular appearance of acidic fibrohlast growth factor. J. Biol. Chem. 270:17457-17467.
64. Oude Essink, B. B., A. T. Das, and B. Berkhout. 1995. Structural requirements for the binding of tRNALys3 to reverse transcriptase of the human immunodeficiency virus type 1. J. Biol. Chem. 270:23867-23874.
65. Panel, A. C., W. A. Haseltine, D. Baltimore, G. Peters, F. Harada, and J. Dahlberg. 1975. Specific binding of tRNAtrp to AMV reverse transcriptase. Proc. Natl. Acad. Sci. USA 72:2535-2539.
66. Pop, M. P., and C. K. Biebricher. 1996. Kinetic analysis of pausing and fidelity of human immunodeficiency virus type 1 reverse transcription. Biochemistry 35:5054-5062.
67. Priel, E., S. D. Showalter, M. Roberts, S. Oroszlan, S. Segal, M. Aboud, and D. G. Blair. 1990. Topoisomerase 1 activity associated with human immunodeficiency virus (HIV) particles and equine infectious anemia virus core. EMBO J. 9:4167-4172.
68. Schwartz, O., V. Marechal, O. Danos, and J. M. Heard. 1995. Human immunodeficiency virus type 1 nef increases the efficiency of reverse transcription in the infected cell. J. Virol. 69:4053-4059.
69. Shi, B., J. Raina, A. Lorenzo, J. Busciglio, and D. Gabuzda. 1998. Neuronal apoptosis induced by HIV-1 Tat protein and TNF-alpha: potentiation of neurotoxicity mediated by oxidative stress and implications for HIV-1 dementia. J. Neurovirol. 4:281-290.
70. Sova, P., and D. J. Volsky. 1993. Efficiency of viral DNA synthesis during infection of permissive and nonpermissive cells with Vif-negative human immunodeficiency virus type 1. J. Virol. 67:6322-6326.
71. Stevenson, M., T. L. Stanwick, M. P. Dempsey, and C. A. Lamonica. 1990. HIV-1 replication is controlled at the level of T cell activation and proviral integration. EMBO J. 9:1551-1560.
72. Temin, H. M., and S. Mitzutani. 1970. RNA-directed DNA polymerase in virions of Rous sarcoma virus. Nature 226:1211-1213.
73. Thali, M., A. Bukovsky, E. Kondo, B. Rosenwirth, C. T. Walsh, J. Sodroski, and H. G. Gottlinger. 1994. Functional association of cyclophilin A with HIV-1 virions. Nature 372:363-365.
74. Ulich, C., D. Harrich, P. Estes, and R. B. Gaynor. 1996 Inhibition of human immunodeficiency virus type 1 replication is enhanced by a combination of transdominant Tat and Rev proteins. J. Virol. 70:4871-4876.
75. von Schwedler, U., R. S. Kombluth, and D. Trono. 1994. The nuclear localization signal of the matrix protein of human immunodeficiency virus type 1 allows the establishment of infection in macrophages and quiescent T-lymphocytes. Proc. Natl. Acad. Sci. USA 91:6992-6996.
76. von Schwedler, U., J. Song, C. Aiken, and D. Trono. 1993. vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells. J. Virol. 67:4945-4955.
77. Wei, P., M. E. Garber, S. M. Fang, W. H. Fischer, and K. A. Jones. 1998. A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, top-specific binding to TAR RNA. Cell 92:451-462.
78. Westendorp, M. O., R. Frank, C. Ochsenbauer, K. Stricker, J. Dhein, H. Walczak, K.-M. Debatin, and P. H. Krammer. 1995. Sensitization of T-cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature 375:497-500.
79. Zack, J. A., S. J. Arrigo, S. R. Weitsman, A. S. Go, A. Haislip, and 1. S. Y. Chen. 1990. HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 61:213-222.
80. Zhu, Y., T. Peery, J. Peng, Y. Ramanathan, N. Marshall, T. Marshall, B. Amendt, M. B. Mathews, and D. H. Price. 1997. Transcription elongation factor P-TEFb is required for HIV-1 Tat transactivation in vitro. Genes Dev. 11:2622-2632.